Plus Therapeutics

PSTV

3.6590.80% ( +0.029 )

Trading: Jul 30, 10:04:05 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Plus Therapeutics(PSTV) predict that the Revenue is 1.028 M (-2.93%), Beat estimate;the EBIT is -7.119 M (-101.3%), Miss estimate;the EPS is -1.05 (+96.47%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.00B2.93%

0.00B8.03%

+0.00B5.10%

EBITMiss expectations

-0.01B101.33%

-0.01B51.79%

-0.00B49.54%

EPSMiss expectations

-1.0596.47%

-0.89896.98%

-0.15200.51%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD